Medicare's national coverage procedures fail to deliver
This article was originally published in Clinica
Executive Summary
Medicare's largely untested process for arriving at national coverage decisions has produced its first casualty. Laboratories offering human tumour drug sensitivity assays have withdrawn their formal request for a national coverage determination from the Health Care Financing Administration (HCFA), the agency that runs the US federal health plan for the elderly and the disabled.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.